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Perivascular epithelioid cell tumors (PEComas) encompass a group of rare mesenchymal neoplasms, which typically
have a perivascular location with dual melanocytic and muscular differentiation. They are found in a variety of
localizations, though lesions in the liver are exceedingly rare. Because of their rarity, the clinical, radiological and
histological features of these tumors have yet to be established. This is why, it seems appropriate to report the
observation of this rare hepatic tumor with a literary review including others published cases, assessing through it,
clinicopathologic and radiologic features of all reported cases as well as their follow-up whenever possible.
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Perivascular epithelioid cell neoplasms (PEComas)
formed a rare group of related mesenchymal tumors
composed of histologically and immunohistochimi-
cally distinctive perivascular cells (PECs), first pro-
posed by Bonetti et al. in 1992. The members of this
family include angiomyolipoma, lymphangioleiom-
yomatosis, pulmonary clear cell “sugar” tumors and
PEComa-NOS [1]. This last entity, first introduced by
Zamboni and al in 1996, to describe neoplasms composed
solely of PECs in his case report [2]. Many anatomic sites
can be affected, but the uterus is the more common. Cases
that arise from the liver are extremely rare [1]. To the best
of our knowledge, Only 20 hepatic PEComas, composed
solely of PECs, have been reported in the current litera-
ture, mostly, as single-case reports.
The following report presents an additional case of
primary liver PEComa appearing in a 63-years-old
woman, followed by a short synopsis about previously
published cases. We discuss the clinicopathological
features, the immunophenotype and the differential
diagnosis to improve awareness about this type of
tumor and how to diagnose it.* Correspondence: ameurtesse@yahoo.com
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A 63-year-old woman presented to gastroenterology
department with a 1-year history of atypical pain in
the right upper abdominal quadrant, with significant
fatigue and weight loss.
Her past medical history was unremarkable. She had no
evidence of cirrhosis, viral hepatitis or tuberous sclerosis
complex (Bourneville’s disease). Physical examination re-
vealed only mild hepatomegaly without palpable mass or
jaundice. Laboratory examinations showed normal liver
function tests and tumoral marquers (AFP, CEA).
Initial abdominal ultrasonography revealed a solitary,
heterogeneous and hypoechoic mass in the liver, with
an ill-demarcated margin. Color Doppler flow images
showed abundant blood flow in the marginal area of the
tumour. Subsequent CT and abdominal MRI confirmed
this intrahepatic mass to be located in the fourth seg-
ment (IV), measuring 6,4 × 8 cm in diameters (Figure 1:
A, B, C, D and E). Neither lymphadenopathy nor portal
vein involvement was present. No additional lesion was
detected. Given the hypervascular character, the lack of
adipose tissue and thick-walled blood vessels, the lesion
has been interpreted as hemangiomas, atypical hepato-
cellular carcinoma or metastatic lesion. Owing to the
deteriorating clinical situation and the ambiguousntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Figure 1 Radiological features of the tumor. A) precontrasted CT scan revealed a low-density mass of segment IV of the liver with ill-defined
borders. B) Contrast CT showing inhomogeneous contrast enhancement of tumor in the portal phase. C) A mass described above had a low
signal on T1-Weighted MRI, it became hyperintense on T2-Weighted images (D), and presented a strong and heterogeneous enhancement
after injection of gadolinium (E).
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with a cholecystectomy was performed.
Gross examination revealed a 6 × 8 cm, solitary lesion
with an ill-demarcated margin. The external surface of
the mass was smooth, white-tan in color. Cut sectionsthrough the mass showed solid and tiny cystic areas with
multiples congested blood vessels. The hepatic tissues
around the mass were normal. The authors took 15 sec-
tions from different parts of the tumor and 2 sections
from the adjacent liver.
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formalin-fixed, paraffin-embedded tissue ware examined.
Histologically, the tumor was composed of nests and
sheets of larges and round to polygonal cells, separated by
a rich sinusoidal vascular network. The cells showed abun-
dant cytoplasm that varied from eosinophilic granular to
clear, with distinct cell border. The nuclei were round to
oval with finely distributed to vesicular chromatin and
small nucleoli. Focal nuclear pleomorphism was observed,
without necrosis, mitotic figures or angiolymphatic inva-
sion [Figure 2]. The tumor frequently showed dilated
vascular channels with radial arrangement of tumor cells.
In numerous sections, adipocytes, thick-walled vessels andFigure 2 Histopathological features of the proliferation. A) ill-defined
adjacent liver. The cytoplasm abundant clear to eosinophilic, with distinct b
and small nucleoli. Focal nuclear pleomorphism was observed. H&E. A, × 100,hematopoietic cells were entirely absent. The adjacent
liver was microscopically normal.
Immunohistochemical study showed a strong and
diffuse expression of HMB45 and smooth muscle actin
(SMA), while Melan-A was focally positive. The neoplas-
tic cells were negative for S100 protein and Pancytokera-
tin [Figure 3].
On the basis of the morphologic characteristics and
immunohistochemical results, a diagnosis of hepatic
PEComa was made, with infiltration of the margins.
The patient recovered uneventfully and was discharged
2 weeks after surgery, without any adjuvant treatment.
At present, 9 months after the surgery, she is undersheets of pleomorphic round to polygonal epithelioid cells, infiltrating
orders. B) The nuclei were round to oval with finely vesicular chromatin
B, × 200.
Figure 3 Immunohistochemical profile of PECs. IHC × 100 A) Most of epithelioid tumor cells are markedly immunoreactive for HMB45 (A),
and SMA (B). Focal Melan-A immunopositivity was noted (C). S100 protein (D) and Cytokeratin (E) were completely negative. IHC × 100.
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recurrence or metastasis.Bibliographic research
For the literature review, a systematic search for PEComa
related reports published was performed using PubMed[3] with de keywords: PEComa, perivascular epithelioid
cell, angiomyolipoma, liver and HMB45.
Discussion
We have described a hepatic PEComa composed purely
of epithelioid cells with lack of lipocytes and abnormal
vessels. In our case, no other component element of the
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examination of most of the tumour tissue was performed.
The descriptive term “perivascular epithelioid cells
(PECs)” were first proposed by Bonetti et al. in 1992 to
describe an “unusual atypical cell type” which typically
has a perivascular distribution, with dual melanocytic
and myoid differentiation [4]. Despite the lack of evi-
dence of a normal anatomical homologue, in 2002, the
World Health Organization has given formal recognition
to the concept of this novel cell type and of PEC-derived
tumors. “PEComa family” includes now many distinct
clinicopathologic entities such as angiomyolipoma (AML),
lymphangiomyomatosis and clear cell “sugar” tumors of
the lung, [1]. Some of them have been linked to tuberous
sclerosis complex, especially AML of the kidney. The
group comprising solely PECs is rare; it has been discrimi-
nated from classic angiomyolipoma by various appella-
tions including monotypic epithelioid AML, clear cell
myomelanocytic tumor, primary extrapulmonary sugar
tumor, and PEComas-NOS or simple PEComa [5,6]. The
first reported case in the liver was in 2000, when Yamasaki
S described this entity diagnosed incidentally in a 30-
years-old women [7]. Since, twenty prior case reports were
found in a MEDLINE search and we auditioned our case
to this data, the main findings for these cases are summa-
rized in Additional file 1: Table S1 [6-24].
Hepatic PEComa was commonly diagnosed following
abdominal pain or mass, occasionally with incidental
finding. One case had synchronous GIST. No one had
history or symptoms of TSC. The routine laboratory in-
vestigations were noncontributory.
There was a marked female predominance (17 women
and 4 men), and the mean age at diagnosis was 46.3 years
(range 25–60 years). All tumors were presented as a soli-
tary lesion, most often in the right lobe, which poses a
clinical and radiological diagnostic challenge. They varied
from 0.8-17 cm in greatest dimension (mean 8.1 cm).Table 1 Immunohistochemistry in the differential diagnosis o
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CD34 negative positivePEComas exhibit a wide spectrum of imaging findings.
Hepatic PEComas can be of any echogenecity, most often,
with abundant blood flow in or surrounding the lesion. As
our case, on CT scan, most neoplasms present as hypo
intense with significant enhancement on arterial phase.
The portal phase was variable. Almost all lesions reported
show low-signal on T1-weighted images, high-signal on
T2-weighted images. These radiologic findings of hyper-
vascular lesion can be confused, most often, with those of
hepatocellular carcinoma or simple haemangioma [25].
The diagnostic was most often confirmed by pathology
finding. PEComa cells are characterized by their perivas-
cular location, often with radial arrangement around the
vascular lumen. Typically, tumor cells are epithelioid
and spindle-shaped resembling smooth muscle cells, and
tend to have abundant clear to eosinophilic pale granular
cytoplasm [5]. Few cases are reported with prominent
nucleoli and mild nuclear pleomorphism as seen in our
case. The presence of melanin pigment is extremely rare,
reported only in 3 cases [13,19,20].
The most important finding is positive immunostain-
ing with both melanocytic (HMB45 and/or melan A)
and smooth muscle (actin and/or desmin) markers [5].
In all reports, there was a diffuse positivity for HMB45.
Melan A and SMA were frequently positive. S100 pro-
tein, desmin and vimentine were more often negative.
Monotypic epithelioid angiomyolipoma should be
differentiated from epithelioid smooth muscle tumour.
Immunohistochemically or ultrastructurally, both tumours
express markers of smooth muscle differentiation, but
only monotypic epithelioid angiomyolipoma expresses
markers of melanogenesis. Other common differential
diagnoses include hepatic adenoma and carcinoma,
gastrointestinal stromal tumors, epithelioid sarcoma, para-
ganglioma, and metastatic sarcomatoid renal cell carcinoma
as well as oncocytic and clear cell carcinoma. The positivity
for melanocytic markers and the negativity for multiplesf PEComa tumors
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physin confirmed the diagnosis [5,15] (Table 1).
The possibility of metastatic malignant melanoma
should always be removed. In the present case, the
patient had no history or clinical manifestation of
cutaneous or mucosal melanoma. All the more, we
had a negative immunostaining with S100 protein.
This last protein was expressed in many reported
cases [7,15,19-21], thereby making the differential
diagnosis more difficult.
Although the vast majority of reported PEComa
showed a benign course; some are aggressive with
locally destructive recurrences, and distant metastasis.
To date, defined criteria for malignancy in hepatic
PEComa have not been established. Folpe et al. [26] pro-
posed a classification of PEComas into benign, uncertain
malignant potential, and malignant based on the presence
of seven worrisome histological features: Tumor size >
5 cm, infiltrative growth pattern, high nuclear grade,
high cellularity, necrosis, mitotic activity > 1/50 HFP
and vascular invasion. Thereby, PEComa with two or
more worrisome histologic features should be consid-
ered as malignant. Tumors with nuclear neoplasm only
or size more than 5 cm only were considered as a neo-
plasm of uncertain malignant potential. Only one case
of malignant PEComa was reported in the liver [9], in
which the diagnosis was established based on the pres-
ence of metastasis. The microscopic findings, in this
case, were consistent with a benign status except for
size more than 5 cm. Seven were thought to have malig-
nant potential according to Folpe’s criteria, but did not
exhibit recurrence or metastasis. This might be attri-
butable to the fact that the follow-up durations in
these cases were relatively short (3 to 24 month). In
our case the patient exhibited two features that favored
malignancy, tumor size and infiltrative growth pattern,
requiring therefore, a close and long-term follow-up.
There is no specific treatment protocol for hepatic
PEComa; the most of neoplasm were surgically treated
without any adjuvant therapy.Conclusion
Primary PEComas of the liver are still a curiosity and
therefore the diagnostic approach, treatment modalities
and the follow-up are challenging. Their prognosis re-
mains unpredictable; it should be regarded as tumors
with uncertain biological potential that require strict and
long-term follow-up.Consent from the patient
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images.Additional file
Additional file 1: Table S1. Clinical-characteristics, radiographic and
pathologic features, and the follow up of previously reported cases of
hepatic PEComas-NOS.
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